Abstract
Aims
Post-transplant diabetes is a prevalent and consequential complication following kidney transplantation, which significantly augments the risk of cardiovascular disease, graft loss, infection, and mortality, thereby profoundly impacting both graft and patient survival. However, the early stages of post-transplant diabetes often go unnoticed or receive inadequate management. Consequently, this study systematically assesses the incidence of new-onset diabetes after kidney transplantation with the aim to enhance medical staff awareness regarding post-transplantation diabetes and provide clinical management guidance.
Methods
We conducted a comprehensive search across multiple databases including PubMed, Web of Science, Embase, The Cochrane Library, CNKI, Wanfang, VIP, and SinoMed until September 21, 2023. Data extraction was performed using standardized tables and meta-analysis was conducted using Stata 16.0 software. A random effects model was employed to estimate the combined prevalence along with its corresponding 95% confidence interval. The source of heterogeneity was explored using subgroup analysis and sensitivity analysis, while publication bias was assessed through funnel plot and Egger's test. This study has been registered with PROSPERO under the registration number CRD42023465768.
Results
This meta-analysis comprised 39 studies with a total sample size of 16,584 patients. The prevalence of new-onset diabetes after transplantation was found to be 20% [95% CI (18.0, 22.0)]. Subgroup analyses were conducted based on age, gender, body mass index, family history of diabetes, type of kidney donor, immunosuppressive regimen, acute rejection episodes, hepatitis C infection status and cytomegalovirus infection.
Conclusions
The incidence of post-kidney transplantation diabetes is substantial, necessitating early implementation of preventive and control measures to mitigate its occurrence, enhance prognosis, and optimize patients' quality of life.
Clinical trial registration: PROSPERO: CRD42023465768.
Similar content being viewed by others
References
Klangjareonchai T, Eguchi N, Tantisattamo E et al (2021) Current pharmacological intervention and medical management for diabetic kidney transplant recipients. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13030413
Montada-Atin T, Prasad GVR (2021) Recent advances in new-onset diabetes mellitus after kidney transplantation. World J Diabetes 12:541–555. https://doi.org/10.4239/wjd.v12.i5.541
Alkadi MM, Abuhelaiqa E, Jerobin J et al (2020) Prediabetes and older age increase the risk of post-transplantation diabetes mellitus: Qatar experience. Clin Transpl 34:e13892. https://doi.org/10.1111/ctr.13892
Martinez Cantarin MP (2021) Diabetes in kidney transplantation. Adv Chron Kidney Dis 28:596–605. https://doi.org/10.1053/j.ackd.2021.10.004
Ong SC, Rhee CM (2021) Novel management of diabetes in kidney transplantation. Curr Opin Nephrol Hypertens 30:5–13. https://doi.org/10.1097/mnh.0000000000000665
Martin-Moreno PL, Shin HS, Chandraker A (2021) Obesity and post-transplant diabetes mellitus in kidney transplantation. J Clin Med. https://doi.org/10.3390/jcm10112497
Zhang Z, Sun J, Guo M et al (2023) Progress of new-onset diabetes after liver and kidney transplantation. Front Endocrinol (Lausanne) 14:1091843. https://doi.org/10.3389/fendo.2023.1091843
Heldal TF, Ueland T, Jenssen T et al (2018) Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study. Transpl Int 31:510–519. https://doi.org/10.1111/tri.13116
Hagen M, Hjelmesaeth J, Jenssen T et al (2003) A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transpl 18:2154–2159. https://doi.org/10.1093/ndt/gfg338
Werzowa J, Säemann M, Haidinger M et al (2015) Antidiabetic therapy in post kidney transplantation diabetes mellitus. Transpl Rev (Orlando) 29:145–153. https://doi.org/10.1016/j.trre.2015.01.001
Dos Santos Q, Hornum M, Terrones-Campos C et al (2022) Posttransplantation diabetes mellitus among solid organ recipients in a Danish cohort. Transpl Int 35:10352. https://doi.org/10.3389/ti.2022.10352
Kang E, Lee J, Kang DH et al (2022) Clinical outcomes of posttransplantation diabetes mellitus in kidney transplantation recipients: a nationwide population-based cohort study in Korea. Sci Rep 12:21632. https://doi.org/10.1038/s41598-022-25070-z
Wang L, Huang J, Li Y et al (2023) Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients. Endocrine 81:58–66. https://doi.org/10.1007/s12020-023-03374-y
Lin H, Yan J, Yuan L et al (2021) Impact of diabetes mellitus developing after kidney transplantation on patient mortality and graft survival: a meta-analysis of adjusted data. Diabetol Metab Syndr 13:126. https://doi.org/10.1186/s13098-021-00742-4
Chevallier E, Jouve T, Rostaing L et al (2021) pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Rev Clin Pharmacol 14:55–66. https://doi.org/10.1080/17512433.2021.1851596
Yeh H, Lin C, Li YR et al (2020) Temporal trends of incident diabetes mellitus and subsequent outcomes in patients receiving kidney transplantation: a national cohort study in Taiwan. Diabetol Metab Syndr 12:34. https://doi.org/10.1186/s13098-020-00541-3
Dienemann T, Fujii N, Li Y et al (2016) Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Transpl Int 29:1017–1028. https://doi.org/10.1111/tri.12807
Boudreaux JP, Mchugh L, Canafax DM et al (1987) The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 44:376–381. https://doi.org/10.1097/00007890-198709000-00010
Zeng XT, Liu H, Chen X et al (2012) Meta-analysis Series IV: Quality assessment tools for observational studies. Chinese Journal of Evidence-based Cardiovascular Medicine 4:297–299. https://doi.org/10.3969/j.1674-4055.2012.04.004
Rotenstein LS, Ramos MA, Torre M et al (2016) Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. JAMA 316:2214–2236. https://doi.org/10.1001/jama.2016.17324
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F et al (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193–206. https://doi.org/10.1037/1082-989x.11.2.193
Jeon JY, Han-Bit S, Park BH et al (2023) Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients. Endocrinol Metab (Seoul) 38:139–145. https://doi.org/10.3803/EnM.2022.1594
Luo DK (2022) Single-center analysis of risk factors for diabetes mellitus after kidney transplantation in adults. In: Hainan Medical University. https://doi.org/10.27952/d.cnki.ghnyx.2022.000033
Ye Y, Gao J, Liang J et al (2021) Association between preoperative lipid profiles and new-onset diabetes after transplantation in Chinese kidney transplant recipients: a retrospective cohort study. J Clin Lab Anal 35:e23867. https://doi.org/10.1002/jcla.23867
Pham VuT, Nguyen Thi Thuy D, Truong Quy K et al (2021) Serum hs-CRP measured prior transplantation predicts of new-onset diabetes after transplantation in renal transplant recipients. Transpl Immunol 66:101392. https://doi.org/10.1016/j.trim.2021.101392
Helvaci Ö, Korucu B, Yeter HH et al (2021) TCF7L2 (rs7903146) but not CDKAL1 (rs7754840) gene polymorphisms increase the risk of new-onset diabetes after kidney transplant. Exp Clin Transpl. https://doi.org/10.6002/ect.2020.0335
Kirnap NG, Bozkus Y, Haberal M (2020) Analysis of risk factors for posttransplant diabetes mellitus after kidney transplantation: single-center experience. Exp Clin Transpl 18:36–40. https://doi.org/10.6002/ect.TOND-TDTD2019.O8
Cheng CY, Feng YT, Wang HY (2020) Incidence and relative risk factors in posttransplant diabetes mellitus patients: a retrospective cohort study. Korean J Transpl 34:213–237. https://doi.org/10.4285/kjt.20.0026
Bang JB, Oh CK, Kim YS et al (2020) Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study. Endocrinol Metab (Seoul) 35:820–829. https://doi.org/10.3803/EnM.2020.743
Ajabnoor A, Nasser M, Khan N et al (2020) Evaluation of tacrolimus trough level in patients who developed post-transplant diabetes mellitus after kidney transplantation: a retrospective single-center study in Saudi Arabia. Transplant Proc 52:3160–3167. https://doi.org/10.1016/j.transproceed.2020.05.014
Dong F (2020) Analysis of influencing factors and islet function of blood glucose in patients with abnormal glucose metabolism after kidney transplantation. In: Qingdao University. https://doi.org/10.27262/d.cnki.gqdau.2020.000434
Londero TM, Giaretta LS, Farenzena LP et al (2019) Microvascular complications of posttransplant diabetes mellitus in kidney transplant recipients: a longitudinal study. J Clin Endocrinol Metab 104:557–567. https://doi.org/10.1210/jc.2018-01521
Lai XQ, Zhang L, Fang JL et al (2019) OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients. Ann Transl Medi. https://doi.org/10.21037/atm.2019.10.14
Choudhury P, Mukhopadhyay P, Roychowdhary A et al (2019) Prevalence and predictors of “New-onset diabetes after transplantation” (NODAT) in renal transplant recipients: an observational study. Indian J Endocrinol Metab 23:273–277. https://doi.org/10.4103/ijem.IJEM-178-19
Biró B, Szabó RP, Illésy L et al (2019) Regulatory T cells in the context of new-onset diabetes after renal transplant: a single-center experience. Transpl Proc 51:1234–1238. https://doi.org/10.1016/j.transproceed.2019.03.007
Lai XQ, Zhang L, Fang JL et al (2019) Analysis of risk factors for post-transplant diabetes mellitus in patients with renal transplants. Chin J Endocr Surg 13:450–455. https://doi.org/10.3760/cma.j.issn.1674-6090.2019.06.003
Xue M, Zhao C, Lv C et al (2018) Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation. J Diabetes 10:857–865. https://doi.org/10.1111/1753-0407.12663
Xu J, Xu L, Wei X et al (2018) Incidence and risk factors of posttransplantation diabetes mellitus in living donor kidney transplantation: a single-center retrospective study in China. Transpl Proc 50:3381–3385. https://doi.org/10.1016/j.transproceed.2018.08.007
Gomes V, Ferreira F, Guerra J et al (2018) New-onset diabetes after kidney transplantation: incidence and associated factors. World J Diabetes 9:132–137. https://doi.org/10.4239/wjd.v9.i7.132
Meng PP (2018) Risk factors and pathogenesis of new-onset diabetes after kidney transplantation. In: Qingdao University. CNKI:CDMD:2.1018.880663
Ahmed I, Osman RKH, Khalifa NO et al (2017) New-onset diabetes after transplant in a Sudanese renal transplant population: prevalence and risk factors. Exp Clin Transpl 15:627–630. https://doi.org/10.6002/ect.2016.0198
Yang J, Fang F, Yang F (2017) Risk factors of new-onset diabetes mellitus after kidney transplantation: a retrospective study. Chin J Tissue Eng Res 21:3275–3280. https://doi.org/10.3969/j.issn.2095-4344.2017.20.025
Porrini EL, Díaz JM, Moreso F et al (2016) Clinical evolution of post-transplant diabetes mellitus. Nephrol Dial Transpl 31:495–505. https://doi.org/10.1093/ndt/gfv368
Aleid H, Alhuraiji A, Alqaraawi A et al (2016) New-onset diabetes after kidney transplantation: Incidence, risk factors, and outcomes. Saudi J Kidney Dis Transpl 27:1155–1161. https://doi.org/10.4103/1319-2442.194603
Li N (2016) Status of diabetes mellitus and its relationship with anxiety and depression in patients with renal transplantation. In: Shandong University. https://doi.org/10.7666/d.Y3036078
Wang YJ, Di WJ, Sun Q et al (2015) Post-transplantation diabetes mellitus and the risk factors. Chin J Nephrol Dial Transpl 24:21–25
Yao B, Chen X, Shen FX et al (2013) The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. Transpl Proc 45:194–196. https://doi.org/10.1016/j.transproceed.2012.08.019
Borda B, Lengyel C, Szederkényi E et al (2012) Post-transplant diabetes mellitus—risk factors and effects on the function and morphology of the allograft. Acta Physiol Hung 99:206–215. https://doi.org/10.1556/APhysiol.99.2012.2.14
He CY, Bi HM (2012) Clinical features and risk factors of diabetes mellitus after kidney transplantation. Pract Geriatr 26:50–52. https://doi.org/10.3969/j.issn.1003-9198.2012.01.014
Xu Y, Liang JX, Liu B et al (2011) Prevalence and long-term glucose metabolism evolution of post-transplant diabetes mellitus in Chinese renal recipients. Diabetes Res Clin Pract 92:11–18. https://doi.org/10.1016/j.diabres.2010.12.006
Ergün I, Keven K, Sengül S et al (2011) Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A. Int Urol Nephrol 43:543–548. https://doi.org/10.1007/s11255-010-9786-8
Borda B, Szederkényi E, Lengyel C et al (2011) Functional and histopathologic changes in renal transplant patients with new-onset diabetes and dyslipidemia. Transpl Proc 43:1254–1258. https://doi.org/10.1016/j.transproceed.2011.03.091
Li J, Liu JD, Li W (2011) Risk factors for new-onset diabetes after kidney transplantation. China Modern Doctor 49:18–19. https://doi.org/10.3969/j.issn.1673-9701.2011.14.008
Marrero D, Hernandez D, Tamajón LP et al (2010) Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish study. NDT Plus 3:ii15–ii20. https://doi.org/10.1093/ndtplus/sfq065
Gnatta D, Keitel E, Heineck I et al (2010) Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. Transpl Proc 42:475–478. https://doi.org/10.1016/j.transproceed.2010.02.021
Mollar-Puchades MA, Malek-Marin T, Merino-Torres JF et al (2009) Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Invest 32:263–266. https://doi.org/10.1007/bf03346464
Chen X, Yao B, Dong TT et al (2009) The characteristics and risk factors for post-transplantation diabetes mellitus. Zhonghua Nei Ke Za Zhi 48:547–551
Mazali FC, Lalli CA, Alves-Filho G et al (2008) Posttransplant diabetes mellitus: incidence and risk factors. Transpl Proc 40:764–766. https://doi.org/10.1016/j.transproceed.2008.03.018
Liu HT, Peng LK, Xie XB et al (2006) Clinic analysis of post-transplant diabete mellitus in kidney transplant recipients. Chin J Mod Oper Surg 10:215–217. https://doi.org/10.3969/j.issn.1009-2188.2006.03.018
Cho YM, Park KS, Jung HS et al (2003) High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care 26:1123–1128. https://doi.org/10.2337/diacare.26.4.1123
Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne) 4:37. https://doi.org/10.3389/fendo.2013.00037
Jenssen T, Hartmann A (2019) Post-transplant diabetes mellitus in patients with solid organ transplants. Nat Rev Endocrinol 15:172–188. https://doi.org/10.1038/s41574-018-0137-7
Rysz J, Franczyk B, Radek M et al. (2021) Diabetes and Cardiovascular Risk in Renal Transplant Patients. Int J Mol Sci 22. https://doi.org/10.3390/ijms22073422
Ohn JH, Kwak SH, Cho YM et al (2016) 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol 4:27–34. https://doi.org/10.1016/s2213-8587(15)00336-8
Pham PT, Pham PM, Pham SV et al (2011) New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 4:175–186. https://doi.org/10.2147/dmso.S19027
Rodríguez-Rodríguez AE, Porrini E, Hornum M et al (2021) Post-transplant diabetes mellitus and prediabetes in renal transplant recipients: an update. Nephron 145:317–329. https://doi.org/10.1159/000514288
Davidson J, Wilkinson A, Dantal J et al. (2003) New-onset diabetes after transplantation: 2003 international consensus guidelines. In: Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75:Ss3–24. https://doi.org/10.1097/01.Tp.0000069952.49242.3e
Conte C, Secchi A (2018) Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention. Acta Diabetol 55:763–779. https://doi.org/10.1007/s00592-018-1137-8
Sharif A, Moore R, Baboolal K (2008) Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation 85:353–358. https://doi.org/10.1097/TP.0b013e3181605ebf
Chowdhury TA (2019) Post-transplant diabetes mellitus. Clin Med (Lond) 19:392–395. https://doi.org/10.7861/clinmed.2019-0195
Maskey R (2014) New-onset diabetes after transplant (NODAT). Kathmandu Univ Med J (KUMJ) 12:301–305. https://doi.org/10.3126/kumj.v12i4.13740
Palepu S, Prasad GV (2015) New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J Diabetes 6:445–455. https://doi.org/10.4239/wjd.v6.i3.445
Razeghi E, Heydarian P, Amerian M et al (2010) The risk factors for diabetes mellitus after kidney transplantation. Saudi J Kidney Dis Transpl 21:1038–1043
Cheng F, Li Q, Wang J et al (2022) Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation. Saudi Pharm J 30:1088–1094. https://doi.org/10.1016/j.jsps.2022.05.013
Anonymous (2014) Standards of medical care in diabetes–2014. Diabetes Care 37(Suppl 1):S14-80. https://doi.org/10.2337/dc14-S014
Gulsoy Kirnap N, Bozkus Y, Haberal M (2020) Analysis of risk factors for posttransplant diabetes mellitus after kidney transplantation: single-center experience. Exp Clin Transpl 18:36–40. https://doi.org/10.6002/ect.TOND-TDTD2019.O8
Gourishankar S, Jhangri GS, Tonelli M et al (2004) Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transpl 4:1876–1882. https://doi.org/10.1111/j.1600-6143.2004.00591.x
Aregbesola A, Voutilainen S, Virtanen JK et al (2017) Gender difference in type 2 diabetes and the role of body iron stores. Ann Clin Biochem 54:113–120. https://doi.org/10.1177/0004563216646397
Issaka A, Cameron AJ, Paradies Y et al (2022) Effect of age and sex on the associations between potential modifiable risk factors and both type 2 diabetes and impaired fasting glycaemia among West African adults. BMC Public Health 22:1211. https://doi.org/10.1186/s12889-022-13588-w
Yeap BB, Wittert GA (2022) Testosterone, diabetes risk, and diabetes prevention in men. Endocrinol Metab Clin North Am 51:157–172. https://doi.org/10.1016/j.ecl.2021.11.004
Ahern T, Wu FC (2015) New horizons in testosterone and the ageing male. Age Ageing 44:188–195. https://doi.org/10.1093/ageing/afv007
Keating NL, O’malley AJ, Smith MR (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24:4448–4456. https://doi.org/10.1200/JCO.2006.06.2497
Kooptiwut S, Hanchang W, Semprasert N et al (2015) Testosterone reduces AGTR1 expression to prevent β-cell and islet apoptosis from glucotoxicity. J Endocrinol 224:215–224. https://doi.org/10.1530/JOE-14-0397
Stam SP, Sokooti S, Eisenga MF et al (2021) Androgens and development of posttransplantation diabetes mellitus in male kidney transplant recipients: a post hoc analysis of a prospective study. Diabetes Care 44:2683–2690. https://doi.org/10.2337/dc21-0237
Navarro G, Xu W, Jacobson DA et al (2016) Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male. Cell Metab 23:837–851. https://doi.org/10.1016/j.cmet.2016.03.015
Lofaro D, Perri A, Aversa A et al (2018) Testosterone in renal transplant patients: effect on body composition and clinical parameters. J Nephrol 31:775–783. https://doi.org/10.1007/s40620-018-0513-3
Dedinská I, Graňák K, Vnučák M et al (2019) Role of sex in post-transplant diabetes mellitus development: Are men and women equal? J Diabetes Complicat 33:315–322. https://doi.org/10.1016/j.jdiacomp.2018.12.017
Ibe A, Smith TC (2014) Diabetes in US women on the rise independent of increasing BMI and other risk factors; a trend investigation of serial cross-sections. BMC Public Health 14:954. https://doi.org/10.1186/1471-2458-14-954
Nagaya T, Yoshida H, Takahashi H et al (2005) Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population. Diabet Med 22:1107–1111. https://doi.org/10.1111/j.1464-5491.2005.01602.x
Conte C, Maggiore U, Cappelli G et al (2020) Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID). Nutr Metab Cardiovasc Dis 30:1427–1441. https://doi.org/10.1016/j.numecd.2020.05.004
Chan W, Bosch JA, Jones D et al (2014) Obesity in kidney transplantation. J Ren Nutr 24:1–12. https://doi.org/10.1053/j.jrn.2013.09.002
Han E, Kim MS, Kim YS et al (2016) Risk assessment and management of post-transplant diabetes mellitus. Metabolism 65:1559–1569. https://doi.org/10.1016/j.metabol.2016.07.011
Stinkens R, Goossens GH, Jocken JW et al (2015) Targeting fatty acid metabolism to improve glucose metabolism. Obes Rev 16:715–757. https://doi.org/10.1111/obr.12298
Kwan JM, Hajjiri Z, Metwally A et al (2016) Effect of the obesity epidemic on kidney transplantation: obesity is independent of diabetes as a risk factor for adverse renal transplant outcomes. PLoS ONE 11:e0165712. https://doi.org/10.1371/journal.pone.0165712
Hoogeveen EK, Aalten J, Rothman KJ et al (2011) Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation 91:869–874. https://doi.org/10.1097/TP.0b013e3182100f3a
Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754. https://doi.org/10.2337/dci19-0014
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403. https://doi.org/10.1056/NEJMoa012512
Courivaud C, Ladrière M, Toupance O et al (2011) Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation. Clin Transpl 25:794–799. https://doi.org/10.1111/j.1399-0012.2010.01367.x
Cosentino F, Grant PJ, Aboyans V et al (2020) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41:255–323. https://doi.org/10.1093/eurheartj/ehz486
Zamora-Ginez I, Pérez-Fuentes R, Baez-Duarte BG et al (2012) Risk factors for diabetes, but not for cardiovascular disease, are associated with family history of Type 2 diabetes in subjects from central Mexico. Ann Hum Biol 39:102–107. https://doi.org/10.3109/03014460.2011.645507
Ertuglu LA, Porrini E, Hornum M et al (2021) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transpl Int 34:1341–1359. https://doi.org/10.1111/tri.13883
Lv C, Chen M, Xu M et al (2014) Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate. PLoS ONE 9:e99406. https://doi.org/10.1371/journal.pone.0099406
Lancia P, Adam De Beaumais T, Elie V et al (2018) Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus. Pediatr Nephrol 33:1045–1055. https://doi.org/10.1007/s00467-017-3881-3
Shivaswamy V, Boerner B, Larsen J (2016) Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev 37:37–61. https://doi.org/10.1210/er.2015-1084
Cheungpasitporn W, Thongprayoon C, Harindhanavudhi T et al (2016) Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. Endocr Res 41:142–147. https://doi.org/10.3109/07435800.2015.1094088
Garnier AS, Duveau A, Planchais M et al (2018) Serum magnesium after kidney transplantation: a systematic review. Nutrients. https://doi.org/10.3390/nu10060729
Yu H, Kim H, Baek CH et al (2016) Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study. BMC Nephrol 17:106. https://doi.org/10.1186/s12882-016-0321-8
Muduma G, Saunders R, Odeyemi I et al (2016) Systematic review and meta-analysis of tacrolimus versus ciclosporin as primary immunosuppression after liver transplant. PLoS ONE 11:e0160421. https://doi.org/10.1371/journal.pone.0160421
Baron PW, Infante S, Peters R et al (2017) Post-transplant diabetes mellitus after kidney transplant in hispanics and caucasians treated with tacrolimus-based immunosuppression. Ann Transpl 22:309–314. https://doi.org/10.12659/aot.903079
Jehn U, Wiedmer N, Boeckel GR et al (2022) Fast tacrolimus metabolism does not promote post-transplant diabetes mellitus after kidney transplantation. Int J Mol Sci. https://doi.org/10.3390/ijms23169131
Alghanem SS, Soliman MM, Alibrahim AA et al (2020) Monitoring tacrolimus trough concentrations during the first year after kidney transplantation: a national retrospective cohort study. Front Pharmacol 11:566638. https://doi.org/10.3389/fphar.2020.566638
Andrade-Sierra J, Contreras AM, Monteon FJ et al (2006) Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients. Arch Med Res 37:961–966. https://doi.org/10.1016/j.arcmed.2006.05.004
Ahmed SH, Biddle K, Augustine T et al (2020) Post-transplantation diabetes mellitus. Diabetes Ther 11:779–801. https://doi.org/10.1007/s13300-020-00790-5
Fabrizi F, Martin P, Dixit V et al (2005) Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transpl 5:2433–2440. https://doi.org/10.1111/j.1600-6143.2005.01040.x
Singh T, Peery S, Astor BC et al (2019) Cause of end-stage renal disease is not a risk factor for cytomegalovirus infection after kidney transplant. Transpl Proc 51:1810–1815. https://doi.org/10.1016/j.transproceed.2019.02.029
Dedinská I, Laca Ľ, Miklušica J et al (2016) Correlation between CMV infection and post-transplantation new-onset diabetes mellitus. Int J Organ Transpl Med 7:173–182
Acknowledgements
I would like to express our gratitude to the Ministry of Science and Technology of the People's Republic of China for their generous financial support, as well as to acknowledge the invaluable technical assistance provided by the school library. I express my sincere gratitude to Professor Yunlan Jiang for his invaluable advice and guidance, which greatly enhanced the quality of this research. Additionally, I would like to extend my appreciation to Tao Li, Xiaodong Yi, Shang Song, and Jing Kang for their valuable assistance in data collection.
Funding
The Ministry of Science and Technology of China’s initiative on "Active health and aging Science and technology Response". (2020YFC2003104).
Author information
Authors and Affiliations
Contributions
Qiufeng Du was responsible for the conception, design, analysis and interpretation of the results, as well as the writing of the paper. Tao Li and Xiaodong Yi were responsible for data collection and organization. Shuang Song and Jing Kang were in charge of statistical processing. Yunlan Jiang conducted feasibility analysis of the article, had overall responsibility for it, ensured quality control, and performed proofreading.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no potential conflicts of interest to disclose.
Date of submission
This study was submitted on October 17, 2023.
Research involving Human Participants and/or Animals
Not applicable.
Informed consent
Not applicable.
Additional information
Managed by Giuseppe Pugliese.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1
Appendix 2
Appendix 1: Search strategy | |
Database | Index and keyword terms |
PubMed | ("Kidney Transplantation"[Mesh Terms] OR ("Renal Transplantation"[Title/Abstract] OR "Renal Transplantations"[Title/Abstract] OR "Transplantations, Renal"[Title/Abstract] OR "Transplantation, Renal"[Title/Abstract] OR "Grafting, Kidney"[Title/Abstract] OR "Kidney Grafting"[Title/Abstract] OR "Transplantation, Kidney"[Title/Abstract] OR "Kidney Transplantations"[Title/Abstract] OR "Transplantations, Kidney"[Title/Abstract] AND ("Diabetes Mellitus"[Mesh Terms] OR "Diabetes Insipidus"[Mesh Terms] OR "diabetes mellitus"[Title/Abstract] OR "diabetes insipidus"[Title/Abstract] OR "Diabete*"[Title/Abstract] OR "Diabetic*"[Title/Abstract] OR "post-transplant diabetes mellitus"[Title/Abstract] OR("new-onset diabetes"[Title/Abstract] OR "new-onset diabetes mellitus"[Title/Abstract] OR "new-onset diabetes after transplantation"[Title/Abstract] OR "new-onset diabetes mellitus after transplantation"[Title/Abstract] OR "PTDM"[Title/Abstract] OR "NODAT"[Title/Abstract] AND ("prevalence"[MeSH Terms] OR "incidence"[MeSH Terms] OR "epidemiology"[MeSH Terms] OR "prevalence*"[Title/Abstract] OR "occurrence*"[Title/Abstract] OR "frequenc*"[Title/Abstract] OR "incidence*"[Title/Abstract] OR "epidemiology*"[Title/Abstract]) |
Web of science | (ALL = ("kidney transplantation" OR "renal transplantation") AND ALL = ("diabetes mellitus" OR "diabete*" OR "diabetic*" OR "post-transplant diabetes mellitus" OR "new-onset diabetes" OR "new-onset diabetes mellitus" OR "new-onset diabetes after transplantation" OR "new-onset diabetes mellitus after transplantation" OR "PTDM" OR "NODAT") AND ALL = ("prevalence*" OR "occurrence*" OR "frequenc*" OR "incidence*" OR "epidemiology*") |
EMBASE | ('kidney transplantation':exp OR 'kidney transplantation':ti,ab OR 'renal transplantation':ti,ab) AND ('diabetes mellitus':exp OR 'diabetes mellitus':ti,ab OR 'diabete*':ti,ab OR 'diabetic*':ti,ab OR 'post-transplant diabetes mellitus':ti,ab OR 'new-onset diabetes':ti,ab OR 'new-onset diabetes mellitus':ti,ab OR 'new-onset diabetes after transplantation':ti,ab OR 'new-onset diabetes mellitus after transplantation':ti,ab OR 'PTDM':ti,ab OR 'NODAT':ti,ab) AND ('prevalence':exp OR 'incidence':exp OR 'frequency':exp OR 'epidemiology':exp OR prevalence:ti,ab OR incidence*:ti,ab OR occurrence*:ti,ab OR frequenc*:ti,ab OR epidemiology*:ti,ab) |
The Cochrane Library | (MeSH descriptor: [Kidney Transplantation] OR ("kidney transplantation"):ti,ab,kw OR ("renal transplantation"):ti,ab,kw) AND (MeSH descriptor: [Diabetes Mellitus] OR ("diabetes mellitus"):ti,ab,kw OR ("diabete*"):ti,ab,kw OR ("diabetic*"):ti,ab,kw OR ("post-transplant diabetes mellitus"):ti,ab,kw OR ("new-onset diabetes"):ti,ab,kw OR ("new-onset diabetes mellitus"):ti,ab,kw OR ("new-onset diabetes after transplantation"):ti,ab,kw OR ("new-onset diabetes mellitus after transplantation"):ti,ab,kw OR ("PTDM"):ti,ab,kw OR ("NODAT"):ti,ab,kw) AND (MeSH descriptor: [Prevalence] OR ("prevalence*"):ti,ab,kw OR ("occurrence*"):ti,ab,kw OR ("frequenc*"):ti,ab,kw OR ("incidence*"):ti,ab,kw OR ("epidemiology*"):ti,ab,kw) |
Appendix 3
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Du, Q., Li, T., Yi, X. et al. Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. Acta Diabetol (2024). https://doi.org/10.1007/s00592-024-02253-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00592-024-02253-w